综合性ST段升高心肌梗塞协议与主要过程指标的关联,用于初级皮肤冠状动脉干预转移的患者中
Radoslav Zinoviev1, Anirudh Kumar2, Chetan P Huded3
1Division of Cardiology University of California Los Angeles Los Angeles CA USA.
Journal of the American Heart Association
|May 2, 2025
概括
一个新的全面的STEMI协议改善了心脏病发作患者的门到气球的时间. 这导致了更好的治疗和降低了30天死亡率,提高了STEMI护理.
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
- 改善医疗保健系统的改善
背景情况:
- 大多数美国ST段升高心肌梗塞 (STEMI) 患者转移进行皮肤穿冠状动脉干预 (PCI) 并未达到门到气球时间 (D2BT) 目标≤120分钟.
- 及时的再输血治疗对于STEMI结果至关重要.
- 现有的协议往往无法优化STEMI护理途径.
研究的目的:
- 评估全面的STEMI协议 (CSP) 对STEMI流程指标的影响.
- 评估指南导向医疗疗,辐射接入和D2BT的改善情况.
- 确定CSP对STEMI患者30天死亡率的影响.
主要方法:
- 实施了4个步骤的CSP,包括ED心脏导管实验室激活,STEMI安全交付清单,立即转移和PCI的辐射第一方法.
- 对1274名转移PCI的STEMI患者进行了比较分析,分为前CSP (n=499) 和CSP (n=775) 组.
- 在CSP实施之前和之后,分析了关键指标,包括医疗疗使用,访问地点,D2BT和30天死亡率.
主要成果:
- 使用指导方针导向的医疗治疗从84.6%增加到93.9% (P<0.001).
- 辐射接入显著增加,从19.0%增加到77.7% (P<0.001).
- 中位数D2BT从114分钟减少到97分钟 (P<0.001),其中80.1%的患者在CSP后达到D2BT≤120分钟,而在CSP前为55.7%.
结论:
- 综合性STEMI协议显著改善了STEMI患者的关键过程指标.
- 实施CSP与门到气球时间的大幅减少有关.
- 达到D2BT <120分钟与30天死亡率相对风险降低50%相关.
更多相关视频
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.2K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.2K
相关概念视频
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...